Eur Heart J:空气污染与急性冠脉综合症患者存活率有关

2013-05-29 Eur Heart J dxy

大量研究表明长期暴露于空气污染环境,特别是不溶性微粒,与心血管疾病发病有关。心肌缺血患者可能对空气污染更敏感。近期,伦敦卫生和热带医学学校的开展了相关研究,目的是应用英格兰和威尔士心肌缺血国家审计项目的相关资料明确心肌缺血患者所有病因导致的死亡率是否与长期暴露于空气污染环境有关,并进一步阐明空气污染暴露的程度对患者预后社会经济不平等的影响。结果显示,空气污染对心脏病患者所有原因导致的死亡率有影响。

大量研究表明长期暴露于空气污染环境,特别是不溶性微粒,与心血管疾病发病有关。心肌缺血患者可能对空气污染更敏感。近期,伦敦卫生和热带医学学校的开展了相关研究,目的是应用英格兰和威尔士心肌缺血国家审计项目的相关资料明确心肌缺血患者所有病因导致的死亡率是否与长期暴露于空气污染环境有关,并进一步阐明空气污染暴露的程度对患者预后社会经济不平等的影响。结果显示,空气污染对心脏病患者所有原因导致的死亡率有影响。

国家心血管研究成果研究所收集的心肌缺血国家审计项目中因急性冠脉综合征入院患者的相关记录与模式2004-2010年年度平均空气污染浓度建立联系。应用Cox比例风险模型评估入院后28天开始的死亡率风险比。在同组的154205名患者中,平均随访时间为3.7年,其中有39863名患者死亡。暴露于直径小于等于2.5μm不溶性微粒较高水平的患者死亡率很高(PM2.5;PM,不溶性微粒):PM2.5的环境下,10μg/m3完全校正风险比为1.20(95%可信区间1.04-1.38)。本研究没有观察较大微粒或氮氧化物与死亡率的关系。空气污染对幸存患者社会经济不平等性影响程度很少。

结论如下,在英格兰和威尔士,因急性冠脉综合征入院的幸村患者暴露于PM2.5的空气污染环境时,所有原因导致的死亡率明显升高。尽管贫困地区人群死亡率很高,但对急性冠脉综合症患者预后的社会经济不平等性影响很少。本研究为阐明长期暴露于微粒与患者死亡率的关系提供了实验证据。

Long-term exposure to air pollution is associated with survival following acute coronary syndrome.
AIMS
The aim of this study was to determine (i) whether long-term exposure to air pollution was associated with all-cause mortality using the Myocardial Ischaemia National Audit Project (MINAP) data for England and Wales, and (ii) the extent to which exposure to air pollution contributed to socioeconomic inequalities in prognosis.
METHODS AND RESULTS
Records of patients admitted to hospital with acute coronary syndrome (ACS) in MINAP collected under the National Institute for Cardiovascular Outcomes Research were linked to modelled annual average air pollution concentrations for 2004-10. Hazard ratios for mortality starting 28 days after admission were estimated using Cox proportional hazards models. Among the 154 204 patients included in the cohort, the average follow-up was 3.7 years and there were 39 863 deaths. Mortality rates were higher for individuals exposed to higher levels of particles with a diameter of ≤2.5 µm (PM2.5; PM, particulate matter): the fully adjusted hazard ratio for a 10 µg/m(3) increase in PM2.5 was 1.20 (95% CI 1.04-1.38). No associations were observed for larger particles or oxides of nitrogen. Air pollution explained socioeconomic inequalities in survival to only a small extent.
CONCLUSION
Mortality from all causes was higher among individuals with greater exposure to PM2.5 in survivors of hospital admission for ACS in England and Wales. Despite higher exposure to PM2.5 among those from more deprived areas, such exposure was a minor contribution to the socioeconomic inequalities in prognosis following ACS. Our findings add to the evidence of mortality associated with long-term exposure to fine particles. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1862865, encodeId=c24d186286521, content=<a href='/topic/show?id=b5ca453451f' target=_blank style='color:#2F92EE;'>#存活率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45345, encryptionId=b5ca453451f, topicName=存活率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3f89, createdName=daviiliu, createdTime=Sun Dec 22 21:07:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355760, encodeId=277f1355e6030, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri May 31 02:07:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472417, encodeId=514a14e2417e5, content=<a href='/topic/show?id=ba4a6436107' target=_blank style='color:#2F92EE;'>#污染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64361, encryptionId=ba4a6436107, topicName=污染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfe67217539, createdName=小刀医生, createdTime=Fri May 31 02:07:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562158, encodeId=63e71562158eb, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Fri May 31 02:07:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1862865, encodeId=c24d186286521, content=<a href='/topic/show?id=b5ca453451f' target=_blank style='color:#2F92EE;'>#存活率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45345, encryptionId=b5ca453451f, topicName=存活率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3f89, createdName=daviiliu, createdTime=Sun Dec 22 21:07:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355760, encodeId=277f1355e6030, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri May 31 02:07:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472417, encodeId=514a14e2417e5, content=<a href='/topic/show?id=ba4a6436107' target=_blank style='color:#2F92EE;'>#污染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64361, encryptionId=ba4a6436107, topicName=污染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfe67217539, createdName=小刀医生, createdTime=Fri May 31 02:07:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562158, encodeId=63e71562158eb, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Fri May 31 02:07:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]
    2013-05-31 zhaojie88
  3. [GetPortalCommentsPageByObjectIdResponse(id=1862865, encodeId=c24d186286521, content=<a href='/topic/show?id=b5ca453451f' target=_blank style='color:#2F92EE;'>#存活率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45345, encryptionId=b5ca453451f, topicName=存活率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3f89, createdName=daviiliu, createdTime=Sun Dec 22 21:07:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355760, encodeId=277f1355e6030, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri May 31 02:07:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472417, encodeId=514a14e2417e5, content=<a href='/topic/show?id=ba4a6436107' target=_blank style='color:#2F92EE;'>#污染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64361, encryptionId=ba4a6436107, topicName=污染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfe67217539, createdName=小刀医生, createdTime=Fri May 31 02:07:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562158, encodeId=63e71562158eb, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Fri May 31 02:07:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1862865, encodeId=c24d186286521, content=<a href='/topic/show?id=b5ca453451f' target=_blank style='color:#2F92EE;'>#存活率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45345, encryptionId=b5ca453451f, topicName=存活率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3f89, createdName=daviiliu, createdTime=Sun Dec 22 21:07:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355760, encodeId=277f1355e6030, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri May 31 02:07:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472417, encodeId=514a14e2417e5, content=<a href='/topic/show?id=ba4a6436107' target=_blank style='color:#2F92EE;'>#污染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64361, encryptionId=ba4a6436107, topicName=污染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfe67217539, createdName=小刀医生, createdTime=Fri May 31 02:07:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562158, encodeId=63e71562158eb, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Fri May 31 02:07:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]
    2013-05-31 slcumt

相关资讯

FDA拒绝批准利伐沙班用于降低ACS患者心脏病和中风发作风险

  强生日前表示,FDA再次拒绝公司旗下利伐沙班用于降低急性冠脉综合征患者心脏病发作和卒中风险的新适应证。   利伐沙班是强生与德国制药商拜耳共同开发的一个产品,早在去年6月份利伐沙班的这一适应证就曾被FDA拒绝过,当时FDA的专家小组对该产品缺失的试验数据和出血风险表示担忧。针对这种情况,强生向FDA补充了利伐沙班临床试验中退出受试者的风险效益数据。   “虽然我们看到利伐沙班严重出血的风险

柳景华,郑斌:急性冠脉综合征抗栓治疗出血与血栓的平衡之道

    急性冠状动脉综合征(acute coronary syndrome, ACS) 是以冠状动脉粥样硬化斑块破裂或糜烂、继发完全或不完全闭塞性血栓形成为病理基础的一组临床综合征,包括不稳定心绞痛(unstable angina, UA)、非ST段抬高心肌梗死(non–ST-elevation myocardial infarction, NSTEMI)和ST段抬高

NEJM:Dalcetrapib对近期有急性冠脉综合征的稳定性冠心病患者的疗效

  背景  在观察性分析中,较高水平的高密度脂蛋白胆固醇(HDL-C)与冠心病事件的较低危险相关。然而,通过治疗升高的HDL-C水平是否降低心血管危险尚不确定。抑制胆固醇酯转运蛋白(CETP)可使HDL-C水平升高,因此有可能改善心血管转归。   方法  我们随机分配15871 例近期有过急性冠脉综合征的患者,除接受最佳可用循证医疗之外,还接受600 mg/d 的CETP 抑

Am J Cardiol:急性冠脉综合征和缺血性卒中危险因素相似

  希腊一项研究表明,急性冠脉综合征和缺血性卒中的相关危险因素基本相似,因此有有利于同时实施一级预防措施。论文4月29日在线发表于《美国心脏病学杂志》(Am J Cardiol)。   此项研究共纳入250例首次急性冠脉综合征患者、250例首次缺血性卒中患者以及500例基于人群的对照者;以1:1比率依据年龄和性别配对。对吸烟/被动吸烟、心血管疾病家族史、无体育活动、高血压、糖

Am J Cardiol:急性冠脉综合征和缺血性卒中危险因素相似

  希腊一项研究表明,急性冠脉综合征和缺血性卒中的相关危险因素基本相似,因此有有利于同时实施一级预防措施。论文4月29日在线发表于《美国心脏病学杂志》(Am J Cardiol)。   此项研究共纳入250例首次急性冠脉综合征患者、250例首次缺血性卒中患者以及500例基于人群的对照者;以1:1比率依据年龄和性别配对。对吸烟/被动吸烟、心血管疾病家族史、无体育活动、高血压、糖

AJC: 非梗阻性与梗阻性冠心病的ACS患者远期死亡相似

  意大利学者的一项研究表明,合并非梗阻性冠状动脉疾病(CAD)的急性冠脉综合征(ACS)患者持续存在长期复发缺血事件的高风险。论文于4月22日在线发表于《美国心脏病学杂志》(Am J Cardiol)。   研究旨在评估ACS合并非梗阻性CAD或梗阻性CAD患者经皮冠状动脉介入治疗(PCI)后患病率、长期转归和口服抗血小板治疗药的依从性。以血管造影显示任何主要心外膜动脉血管